Funded startups/Ember LifeSciences, Inc.
EL

Ember LifeSciences, Inc.

SEC filing
Other Technology · Westlake Village, CA
Form D on EDGAR
Amount raised$32.2Msold at filing
Total offering$50M$17.8M still open
Investors in the raise50count reported to the SEC
FiledAug 20, 2026first sale Jun 16, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Clayton Marie AlexanderExecutive Officer, Director
Brian Marie BejaranoExecutive Officer
Ann Marie HyllengrenExecutive Officer
James Marie DeNautDirector
Timothy WhiteDirector
Michael Marie KaufmannDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AAug 20, 2026$32.2M$50MEDGAR
DMar 3, 2026$20.9M$50MEDGAR